Compounds > ethinyl estradiol-norgestrel combination
Page last updated: 2024-08-22

ethinyl estradiol-norgestrel combination and corticosterone

ethinyl estradiol-norgestrel combination has been researched along with corticosterone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, IK; Olatunji, LA; Seok, YM; Usman, TO1
Adeyanju, OA; Areola, ED; Michael, OS; Olatunji, LA; Soladoye, AO1
Michael, OS; Olatunji, LA1
Adeyanju, OA; Olatunji, LA1

Other Studies

4 other study(ies) available for ethinyl estradiol-norgestrel combination and corticosterone

ArticleYear
Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder.
    Archives of physiology and biochemistry, 2017, Volume: 123, Issue:1

    Topics: Aldosterone; Animals; Ataxia Telangiectasia Mutated Proteins; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dyslipidemias; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Intolerance; Heart; Hyperinsulinism; Hypertension; Insulin Resistance; Metabolic Syndrome; Myocardium; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Random Allocation; Rats, Sprague-Dawley; Renin-Angiotensin System; Up-Regulation

2017
Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Blood Viscosity; Contraceptives, Oral; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fibrinolytic Agents; Glucocorticoids; Insulin Resistance; Levonorgestrel; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley

2017
Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy.
    Archives of physiology and biochemistry, 2018, Volume: 124, Issue:2

    Topics: Administration, Oral; Aldosterone; Animals; Biomarkers; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Glycogen Synthase Kinase 3; Heart; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Levonorgestrel; Myocardium; Nicotine; Nicotinic Agonists; Plasminogen Activator Inhibitor 1; Prediabetic State; Random Allocation; Rats, Wistar

2018
Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone.
    Journal of basic and clinical physiology and pharmacology, 2019, Aug-30, Volume: 30, Issue:5

    Topics: Androstenes; Animals; Blood Glucose; Body Weight; Contraceptives, Oral; Corticosterone; Drug Combinations; Ethinyl Estradiol; Female; Insulin; Insulin-Secreting Cells; Levonorgestrel; Rats

2019